Application of SF3B1 gene mutation in auxiliary diagnosis on prolactin-type pituitary adenoma
A technology for SF3B1 and pituitary adenoma, which is applied in the determination/testing of microorganisms, biochemical equipment and methods, instruments, etc.
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0075]Example 1 Design of primers and TaqMan-MGB probes for detecting SF3B1 c.1874G>A gene mutation
[0076] According to the published SF3B1 gene sequence (GenBank TM Accession number NM_012433.4, the nucleotide sequence of which is shown in SEQID NO: 1) and the SF3B1 c.1874G>A mutation designed primers for the SF3B1 gene and probes for the SF3B1 mutant allele (hereinafter referred to as the mutant Allele probe) and a probe for the wild-type allele of SF3B1 (hereinafter referred to as the wild-type allele probe) to detect the SF3B1 c.1874G>A mutation. in:
[0077] Primers for the SF3B1 gene are primers for complementary probe regions and TaqMan MGB probes (TsingKeBiological Technology), including a primer pair consisting of forward primer SF3B1-PF and reverse primer SF3B1-PR, and their specific sequences are as follows:
[0078] SF3B1-PF: 5'-CTGGCTACTATGATCTCTACCATGAGA-3' (SEQ ID NO: 3)
[0079] SF3B1-PR: 5'-GAGGCTACAACAGCAAAAGCTCTA-3' (SEQ ID NO: 4)
[0080] The mutant a...
Embodiment 2
[0089] Example 2 Detection of SF3B1 c.1874G>A mutation in prolactin (PRL) type pituitary adenoma
[0090] Surgical specimens from radical resection of prolactinogenic pituitary adenoma were collected in the neurosurgery department of the hospital, and each patient signed an informed consent.
[0091] Prolactinogenic pituitary adenoma inclusion criteria:
[0092] 1. Serum prolactin level PRL>90ng / ml.
[0093] 2. Clinical symptoms related to hyperprolactinemia and tumor mass effect, including menopause, lactation, infertility, sexual dysfunction, headache, visual impairment, etc.
[0094] 3. The pathological diagnosis was pituitary adenoma, and the immunohistochemistry showed positive PRL.
[0095] 4. Head MRI / CT showed sellar region lesions.
[0096] This study was approved by the ethics committee.
[0097] The primers designed in Example 1 and the TaqMan-MGB probe were used to detect the SF3B1 c.1874G>A mutation on the test samples of the case group, and at the same time, ...
Embodiment 3
[0135] Example 3 SF3B1 R625H Effects of Mutations on Prolactin Pituitary Adenoma Cells
[0136] Primary prolactin pituitary adenoma cells were infected with adenovirus fluids of wild-type and mutant (SF3B1 c.1874G>A) of SF3B1. Changes in prolactin levels in the cell supernatant were detected. The virus liquid of adenovirus expressing SF3B1 wild-type and mutant (SF3B1c.1874G>A) was purchased from Beijing Biochuan Biotechnology Co., Ltd.
[0137] Primary lactotrophs were divided into the following three groups:
[0138] (1) SF3B1 wild-type group: infected with SF3B1 wild-type adenovirus (adenovirus-SF3B1 WT ) cells, which are cells obtained by infecting primary prolactin pituitary adenoma cells with virus liquid expressing SF3B1 wild-type adenovirus;
[0139] (2) SF3B1 mutant group: infected with SF3B1 mutant adenovirus (adenovirus-SF3B1 R625H ) cells, which are cells obtained by infecting primary prolactin pituitary adenoma cells with virus liquid expressing SF3B1 mutant a...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com